Skip to content

Author

Joey S. Estorosos

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Forecasting HIV Incidence Trajectories in Cebu City, Philippines: An ARIMA-Based Time-Series Analysis for Epidemic Surveillance and Public Health Planning

Background: The Philippines is experiencing one of the fastest-growing HIV epidemics in the Western Pacific region, with Cebu City among the most affected urban centers. However, localized forecasting studies remain limited, constraining evidence-based public health planning and resource allocation. This study aims to develop and evaluate an Autoregressive Integrated Moving Average (ARIMA) model for forecasting monthly HIV incidence in Cebu City. Methods: Monthly HIV surveillance data from January 2022 to March 2025 were analyzed using time-series forecasting. Candidate ARIMA models were assessed using the Akaike Information Criterion (AIC), parameter significance, residual diagnostics, and out-of-sample forecasting accuracy. Results: ARIMA (0,1,1) demonstrated the best predictive performance, achieving a Mean Absolute Percentage Error (MAPE) of 25.04% and outperforming Naïve, Simple Moving Average, and Exponential Smoothing models. Forecasts for April to December 2025 project monthly HIV cases to increase from 33 to 36. Although forecasts suggest a persistent rise in HIV incidence, widening confidence intervals indicate greater uncertainty over longer forecasting horizons. Conclusion: The projected increase in HIV incidence signals a continuing public health challenge in Cebu City. ARIMA-based forecasting provides a practical decision-support tool for anticipating disease trends and informing surveillance, targeted prevention, and healthcare resource allocation.

Jonecis A. Dayap, John Michael B. Genterolizo, Miguelito A. Ruelan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.